MARATTO

article · Journal of the Egyptian Society of Parasitology

IN VITRO RESPONSE OF BLASTOCYSTIS SPP. TO AQUEOUS EXTRACTS OF SOME EGYPTIAN HERBS

2024Open accessSohag University

Abstract

Blastocystis spp. is a protozoan parasite with controversial clinical significance and consensus for treatment. Metronidazole (MTZ) was considered the main line of treatment, but drug resistance and many side effects motivated the search for effective safe therapy. This study evaluated the in vitro therapeutic effects of aqueous extracts of nine Egyptian herbs on Blastocystis spp. compared to MTZ as standard control drug. Blastocystis-positive stool samples were obtained from patients with gastrointestinal symptoms by direct smears and FECT. Aqueous extract of herbal plants (A. sativum, N. sativa, P. nigrum, C. cyminum, Z. officinale, T. vulgaris, O. majorana, M. chamomilla & A. Judaica) were prepared. Positive samples were incubated with 0.1mg/ml concentration of tested herbal extracts on Jones medium at 37ºC versus 0.1mg/ml MTZ as a control. Parasite count was assessed after 24, 48, & 72hr post incubation. The A. sativum, M. chamomilla, A. Judaica & N. sativa extracts showed highly significant growth inhibition rate of Blastocystis species compared to MTZ followed by O. majorana, C. cymin- um & T. vulgaris extract. But, P. nigrum & Z. officinale extracts showed insignificant growth rate.

Research topics

  • Plant Disease Resistance and Genetics
  • Agriculture, Plant Science, Crop Management
  • Silicon Effects in Agriculture

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/jesp.2024.397259

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.